Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38448751)

  • 1. PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.
    Takihira S; Yamada D; Osone T; Takao T; Sakaguchi M; Hakozaki M; Itano T; Nakata E; Fujiwara T; Kunisada T; Ozaki T; Takarada T
    Br J Cancer; 2024 May; 130(9):1493-1504. PubMed ID: 38448751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
    Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
    PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
    Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
    Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
    Skotheim RI; Kallioniemi A; Bjerkhagen B; Mertens F; Brekke HR; Monni O; Mousses S; Mandahl N; Soeter G; Nesland JM; Smeland S; Kallioniemi OP; Lothe RA
    J Clin Oncol; 2003 Dec; 21(24):4586-91. PubMed ID: 14673046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.
    Liu LM; Xiong DD; Lin P; Yang H; Dang YW; Chen G
    Int J Oncol; 2018 Nov; 53(5):1897-1912. PubMed ID: 30132517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
    Peacock JD; Cherba D; Kampfschulte K; Smith MK; Monks NR; Webb CP; Steensma M
    J Transl Med; 2013 Sep; 11():213. PubMed ID: 24040940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.
    Kolberg M; Høland M; Lind GE; Ågesen TH; Skotheim RI; Hall KS; Mandahl N; Smeland S; Mertens F; Davidson B; Lothe RA
    Mol Oncol; 2015 Jun; 9(6):1129-39. PubMed ID: 25769404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
    Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
    BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
    Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
    J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells.
    Zhang F; Wu H
    Biochem Biophys Res Commun; 2021 Sep; 570():154-161. PubMed ID: 34284141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
    Miller SJ; Lan ZD; Hardiman A; Wu J; Kordich JJ; Patmore DM; Hegde RS; Cripe TP; Cancelas JA; Collins MH; Ratner N
    Oncogene; 2010 Jan; 29(3):368-79. PubMed ID: 19901965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
    Karube K; Nabeshima K; Ishiguro M; Harada M; Iwasaki H
    J Clin Pathol; 2006 Feb; 59(2):160-5. PubMed ID: 16443732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
    Patel AV; Eaves D; Jessen WJ; Rizvi TA; Ecsedy JA; Qian MG; Aronow BJ; Perentesis JP; Serra E; Cripe TP; Miller SJ; Ratner N
    Clin Cancer Res; 2012 Sep; 18(18):5020-30. PubMed ID: 22811580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis.
    Cui Y; Pu R; Ye J; Huang H; Liao D; Yang Y; Chen W; Yao Y; He Y
    Dig Dis Sci; 2021 Aug; 66(8):2637-2650. PubMed ID: 32910366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.
    Patel AV; Chaney KE; Choi K; Largaespada DA; Kumar AR; Ratner N
    EBioMedicine; 2016 Jul; 9():110-119. PubMed ID: 27333032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes.
    Piorońska W; Nwosu ZC; Han M; Büttner M; Ebert MP; Dooley S; Meyer C
    BMC Cancer; 2021 Sep; 21(1):1006. PubMed ID: 34496784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.
    Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerase II alpha promotes the metastatic characteristics of glioma cells by transcriptionally activating β-catenin.
    Liu Y; Ma J; Song JS; Zhou HY; Li JH; Luo C; Geng X; Zhao HX
    Bioengineered; 2022 Feb; 13(2):2207-2216. PubMed ID: 35012441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.